$15.6 Million Grants Will Study Parion's Work

Parion Sciences, a Durham company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced that the National Institutes of Health has awarded up to $15.6 million over 5 years in grants for two universities to conduct research with mucolytic agents discovered by the company and to enable Investigational New Drug applications for Parion's molecules.